The role of pericranial muscles in the succesful management of episodic tension type headache

Peripheral and central nociceptive mechanisms are responsible for the development of Tension Type Headache (TTH). Analgesics are frequently used in the treatment of acute TTH. Antidepressants are used in prevention. In this study, the therapeutic efficacy of local application of lidocaine was invest...

Full description

Saved in:
Bibliographic Details
Published in:Aǧrı 2012, Vol.24 (4), p.153-158
Main Authors: Karadaş, Omer, Babacan, Avni, Gül, Levent Hakan, Ipekdal, Ilker Hüseyin, Türk Börü, Ulkü
Format: Article
Language:eng ; tur
Subjects:
Adolescent
Adult
Anesthetics, Local - administration & dosage
Facial Muscles
Female
Humans
Injections, Intramuscular
Lidocaine - administration & dosage
Male
Masticatory Muscles
Middle Aged
Neck Muscles
Pain Measurement
Tension-Type Headache - drug therapy
Tension-Type Headache - etiology
Treatment Outcome
Trigger Points
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Peripheral and central nociceptive mechanisms are responsible for the development of Tension Type Headache (TTH). Analgesics are frequently used in the treatment of acute TTH. Antidepressants are used in prevention. In this study, the therapeutic efficacy of local application of lidocaine was investigated in Episodic Tension Type Headache (ETTH) patients. ETTH patients with pericranial tenderness (n=20, Group 1) and without pericranial tenderness (n=20, Group 2) were included in our study. Three sessions of local injection of 1% lidocaine were performed in both groups. Two-sided intramuscular injections of 1 mL were applied for each patient. The muscles treated were the frontal, temporal, masseter, sternokloidomastoid, semispinalis capitis, splenius capitis and trapezius muscles. Patients were evaluated in 1st, 2nd, and 3rd months. The number of painful days per month and pain intensities were recorded according to Visual Analog Scale (VAS) before and after the treatment. 11 male and 29 female patients were included in the study. The mean ages of Group 1 and Group 2 were 35.95 ± 9.85 (18-53) and 34.85 ± 10.04 (20-54) years, respectively. There was no difference between the groups in terms of age, gender, pain frequency and pain intensity (p>0.05). The frequency and severity of pain was significantly lower in pericranial-sensitive ETTH patients at the 1st, 2nd, and 3rd months after local lidocaine injections compared to ETTH patients having pericranial tenderness (p
ISSN:1300-0012
DOI:10.5505/agri.2012.57704